
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Updated vaccine protects against SARS-CoV-2 variants including Omicron (B.1.1.529) and prevents transmission in hamsters
Sapna Sharma, Thomas Vercruysse, Lorena Sanchez‐Felipe, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 20
Sapna Sharma, Thomas Vercruysse, Lorena Sanchez‐Felipe, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 20
Showing 20 citing articles:
Nanoparticle-based DNA vaccine protects against SARS-CoV-2 variants in female preclinical models
Lays Cordeiro Guimarães, Pedro Augusto Carvalho Costa, Sérgio Scalzo, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 18
Lays Cordeiro Guimarães, Pedro Augusto Carvalho Costa, Sérgio Scalzo, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 18
Cross-protection induced by highly conserved human B, CD4+, and CD8+ T-cell epitopes-based vaccine against severe infection, disease, and death caused by multiple SARS-CoV-2 variants of concern
Swayam Prakash, Nisha R. Dhanushkodi, Latifa Zayou, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 15
Swayam Prakash, Nisha R. Dhanushkodi, Latifa Zayou, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 15
High frequencies of alpha common cold coronavirus/SARS-CoV-2 cross-reactive functional CD4+ and CD8+ memory T cells are associated with protection from symptomatic and fatal SARS-CoV-2 infections in unvaccinated COVID-19 patients
Pierre-Grégoire Coulon, Swayam Prakash, Nisha R. Dhanushkodi, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 8
Pierre-Grégoire Coulon, Swayam Prakash, Nisha R. Dhanushkodi, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 8
YF17D‐based vaccines – standing on the shoulders of a giant
Lorena Sanchez‐Felipe, Yeranddy A. Alpízar, Ji Ma, et al.
European Journal of Immunology (2024) Vol. 54, Iss. 5
Open Access | Times Cited: 6
Lorena Sanchez‐Felipe, Yeranddy A. Alpízar, Ji Ma, et al.
European Journal of Immunology (2024) Vol. 54, Iss. 5
Open Access | Times Cited: 6
Dynamics of spike-specific neutralizing antibodies across five-year emerging SARS-CoV-2 variants of concern reveal conserved epitopes that protect against severe COVID-19
Latifa Zayou, Swayam Prakash, Hawa Vahed, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Latifa Zayou, Swayam Prakash, Hawa Vahed, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Application of Traditional Vaccine Development Strategies to SARS-CoV-2
Halie M. Rando, Ronan Lordan, Alexandra Lee, et al.
mSystems (2023) Vol. 8, Iss. 2
Open Access | Times Cited: 14
Halie M. Rando, Ronan Lordan, Alexandra Lee, et al.
mSystems (2023) Vol. 8, Iss. 2
Open Access | Times Cited: 14
A Broad-Spectrum Multi-Antigen mRNA/LNP-Based Pan-Coronavirus Vaccine Induced Potent Cross-Protective Immunity Against Infection and Disease Caused by Highly Pathogenic and Heavily Spike-Mutated SARS-CoV-2 Variants of Concern in the Syrian Hamster Model
Swayam Prakash, Nisha R. Dhanushkodi, Mahmoud Singer, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 3
Swayam Prakash, Nisha R. Dhanushkodi, Mahmoud Singer, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 3
Pathogenesis and virulence of coronavirus disease: Comparative pathology of animal models for COVID-19
Natalie M. Kirk, Yuying Liang, Hinh Ly
Virulence (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 2
Natalie M. Kirk, Yuying Liang, Hinh Ly
Virulence (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 2
Potent neutralizing anti-SARS-CoV-2 human antibodies cure infection with SARS-CoV-2 variants in hamster model
Maya Imbrechts, Wim Maes, Louanne Ampofo, et al.
iScience (2022) Vol. 25, Iss. 8, pp. 104705-104705
Open Access | Times Cited: 12
Maya Imbrechts, Wim Maes, Louanne Ampofo, et al.
iScience (2022) Vol. 25, Iss. 8, pp. 104705-104705
Open Access | Times Cited: 12
A scientific career from the early 1960s till 2023: A tale of the various protagonists
Erik De Clercq
Biochemical Pharmacology (2024) Vol. 228, pp. 116248-116248
Closed Access | Times Cited: 1
Erik De Clercq
Biochemical Pharmacology (2024) Vol. 228, pp. 116248-116248
Closed Access | Times Cited: 1
Dynamics of Spike-Specific Neutralizing Antibodies Across Five-Year Emerging SARS-CoV-2 Variants of Concern Reveal Conserved Epitopes that Protect Against Severe COVID-19
Latifa Zayou, Swayam Prakash, Hawa Vahed, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Latifa Zayou, Swayam Prakash, Hawa Vahed, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Antigenic imprinting dominates humoral responses to new variants of SARS-CoV-2 in a hamster model of COVID-19
Joran Degryse, Elke Maas, Ria Lassaunière, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Joran Degryse, Elke Maas, Ria Lassaunière, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Cross-Protection Induced by Highly Conserved Human B, CD4+,and CD8+T Cell Epitopes-Based Coronavirus Vaccine Against Severe Infection, Disease, and Death Caused by Multiple SARS-CoV-2 Variants of Concern
Swayam Prakash, Nisha R. Dhanushkodi, Latifa Zayou, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 4
Swayam Prakash, Nisha R. Dhanushkodi, Latifa Zayou, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 4
YF17D-vectored Ebola vaccine candidate protects mice against lethal surrogate Ebola and yellow fever virus challenge
Viktor Lemmens, Lara Kelchtermans, Sarah Debaveye, et al.
npj Vaccines (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 4
Viktor Lemmens, Lara Kelchtermans, Sarah Debaveye, et al.
npj Vaccines (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 4
Preclinical immune efficacy against SARS-CoV-2 beta B.1.351 variant by MVA-based vaccine candidates
Patricia Pérez, Guillermo Albericio, David Astorgano, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 4
Patricia Pérez, Guillermo Albericio, David Astorgano, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 4
Evaluation of a SARS-CoV-2 spike protein ectodomain subunit vaccine with a squalene emulsion adjuvant in rodents and rhesus macaques
Maxim Solomadin, Kairat Tabynov, Nikolai Petrovsky, et al.
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 2
Open Access | Times Cited: 3
Maxim Solomadin, Kairat Tabynov, Nikolai Petrovsky, et al.
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 2
Open Access | Times Cited: 3
Do We Really Need Omicron Spike-Based Updated COVID-19 Vaccines? Evidence and Pipeline
Daniele Focosi, Fabrizio Maggi
Viruses (2022) Vol. 14, Iss. 11, pp. 2488-2488
Open Access | Times Cited: 5
Daniele Focosi, Fabrizio Maggi
Viruses (2022) Vol. 14, Iss. 11, pp. 2488-2488
Open Access | Times Cited: 5
Nanobody against SARS-CoV-2 non-structural protein Nsp9 inhibits viral replication in human airway epithelia
Tomáš Venit, Jérémy Blavier, Sibusiso B. Maseko, et al.
Molecular Therapy — Nucleic Acids (2024) Vol. 35, Iss. 3, pp. 102304-102304
Open Access
Tomáš Venit, Jérémy Blavier, Sibusiso B. Maseko, et al.
Molecular Therapy — Nucleic Acids (2024) Vol. 35, Iss. 3, pp. 102304-102304
Open Access
Antigenic Imprinting Dominates Humoral Responses to New Variants of SARS-CoV-2 in a Hamster Model of COVID-19
Joran Degryse, Elke Maas, Ria Lassaunière, et al.
Microorganisms (2024) Vol. 12, Iss. 12, pp. 2591-2591
Open Access
Joran Degryse, Elke Maas, Ria Lassaunière, et al.
Microorganisms (2024) Vol. 12, Iss. 12, pp. 2591-2591
Open Access
Single-dose YF17D-vectored Ebola vaccine candidate protects mice against both lethal surrogate Ebola and yellow fever virus challenge
Viktor Lemmens, Lara Kelchtermans, Sarah Debaveye, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Viktor Lemmens, Lara Kelchtermans, Sarah Debaveye, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access